Maria Pia Protti

Dr. Maria Pia Protti

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1999 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
TSTiziana Sturniolo
Tiziana Sturniolo
EBElisa Bono
Elisa Bono
JDJiayi Ding
Jiayi Ding
LRLaura Raddrizzani
Laura Raddrizzani
OTOezlem Tuereci
Oezlem Tuereci
JHJuergen Hammer
Juergen Hammer

21 February 2011 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LMLucia De Monte
Lucia De Monte
MRMichele Reni
Michele Reni
ETElena Tassi
Elena Tassi
DCDaniela Clavenna
Daniela Clavenna
IPIlenia Papa
Ilenia Papa
MPMaria Pia Protti
Maria Pia Protti
Pancreatic cancer is a very aggressive disease characterized by a marked desmoplasia with a predominant Th2 (GATA-3+) over Th1 (T-bet+) lymphoid infiltrate. We found that the ratio of GATA-3+/T-bet+ tumor-infiltrating lymphoid cells is an independent predictive marker of patient survival. Patients surgically treated for stage IB/III disease with a ratio inferior to the median value had a statistically significant prolonged overall survival, implying an active role for Th2 responses in disease progression. Thymic stromal lymphopoietin (TSLP), which favors Th2 cell polarization through myeloid dendritic cell (DC) conditioning, was secreted by cancer-associated fibroblasts (CAFs) after activation with tumor-derived tumor necrosis factor α and interleukin 1β. TSLP-containing supernatants from activated CAFs induced in vitro myeloid DCs to up-regulate the TSLP receptor (TSLPR), secrete Th2-attracting chemokines, and acquire TSLP-dependent Th2-polarizing capability in vitro. In vivo, Th2 chemoattractants were expressed in the tumor and in the stroma, and TSLPR-expressing DCs were present in the tumor stroma and in tumor-draining but not in nondraining lymph nodes. Collectively, this study identifies in pancreatic cancer a cross talk between tumor cells and CAFs, resulting in a TSLP-dependent induction of Th2-type inflammation which associates with reduced patient survival. Thus, blocking TSLP production by CAFs might help to improve prognosis in pancreatic cancer.

26 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
ACAmélie Cachot
Amélie Cachot
MBMariia Bilous
Mariia Bilous
YLYen-Cheng Liu
Yen-Cheng Liu
XLXiaokang Li
Xiaokang Li
MSMargaux SAILLARD
Margaux SAILLARD
CJCamilla Jandus
Camilla Jandus
Fully functional, tumor-specific, SLAMF7-expressing cytotoxic CD4 T cells directly mediate immunity against human cancer.

1 July 2016 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
SWSonja M. Wörmann
Sonja M. Wörmann
LSLiang Song
Liang Song
JAJiaoyu Ai
Jiaoyu Ai
KDKalliope Diakopoulos
Kalliope Diakopoulos
MKMagdalena U. Kurkowski
Magdalena U. Kurkowski
HAHana Algül
Hana Algül

1 July 1999 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
ARAnna Ronchetti
Anna Ronchetti
PRPatrizia Rovere
Patrizia Rovere
GIGiandomenica Iezzi
Giandomenica Iezzi
GGGiacomo Galati
Giacomo Galati
SHSilvia Heltai
Silvia Heltai
MBMatteo Bellone
Matteo Bellone
Apoptosis allows the clearance of unwanted cells from living tissues without causing inflammation. Processing of phagocytosed apoptotic cells yields Ags that access the cytosol and the MHC class I pathway of engulfing cells and are recognized by Ag-specific CTL. We show here that injection of apoptotic RMA cells, a syngeneic T cell lymphoma, into C57BL/6 mice results in priming of a functional and long-lasting tumor-specific immune response. Cross-priming of CTLs by apoptotic cells requires CD4+ T cell help. Apoptotic cells, however, are at least 20-fold less immunogenic than nonreplicating live cells. Immunogenicity of apoptotic cells is proportional to the number of cells injected, correlates with the serum concentration of IL-10 and IL-1β cytokines, and is enhanced in IL-10 knockout mice. Moreover, immunization with dendritic cells (DCs), but not macrophages (Mφ), pulsed with apoptotic cells primes tumor-specific CTLs and confers protection against a tumor challenge. Our findings demonstrate that tumor cells undergoing apoptosis are, though scarcely, immunogenic in vivo, outline the different roles of Mφ and DCs in the physiologic clearance of unwanted cells, and have implications in designing immunomodulating vaccines.

1 December 1997 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MBM Bellone
M Bellone
GIG Iezzi
G Iezzi
PRP Rovere
P Rovere
GGG Galati
G Galati
ARA Ronchetti
A Ronchetti
AMA A Manfredi
A A Manfredi
Programmed death via apoptosis is the metazoan physiologic mode of cell death. Apoptotic cells are recognized by scavenger phagocytes via a number of membrane receptors and engulfed. Thereafter, little is known of their fate, or that of phagocytes. Here, we have traced apoptotic cells upon their engulfment by macrophages. After 3 h, apoptotic cells were contained in discrete well-defined vacuoles. Upon overnight chase, several small vesicles, possibly originating from the fragmentation of original vacuoles, were evident all over the macrophage body. Furthermore, Ags were diffused in the cytosol of some cells, which raises the possibility that epitopes from engulfed apoptotic cells may associate with macrophage MHC class I molecules and be recognized by T lymphocytes. Indeed, Ag-specific CTLs recognize and specifically lyse syngeneic macrophages upon phagocytosis of MHC class I-positive or -negative apoptotic cells, provided that they contain the relevant Ags. Synthesis and membrane expression of class I molecules by macrophages, together with functional transporters associated with Ag presentation, were necessary for recognition and lysis. The indirect presentation of epitopes from engulfed apoptotic cells by scavenger Ag-presenting phagocytes may, in the absence of "danger" signals, have implications for the establishment of central and peripheral self-tolerance.